Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Chattopadhyay

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancers|March 13, 2025
Systemic Treatment in Soft Tissue Sarcomas: Are We Making a Difference?Amrit Paudel, Priya Chattopadhyay, Brandon Rose, et al.
Cancers|January 28, 2026
MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue SarcomaHarold Bravo Thompson, Priya Chattopadhyay, Ty Subhawong, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancers|March 13, 2025
Systemic Treatment in Soft Tissue Sarcomas: Are We Making a Difference?Amrit Paudel, Priya Chattopadhyay, Brandon Rose, et al.
Cancers|January 28, 2026
MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue SarcomaHarold Bravo Thompson, Priya Chattopadhyay, Ty Subhawong, et al.
Pageof 1